No Financial Advisors. Except as set forth on Section 2.20 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its Subsidiaries.
Appears in 11 contracts
Samples: Agreement and Plan of Merger (Terra Tech Corp.), Agreement and Plan of Merger and Reorganization (DelMar Pharmaceuticals, Inc.), Agreement and Plan of Merger and Reorganization (Conatus Pharmaceuticals Inc.)
No Financial Advisors. Except as set forth on in Section 2.20 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its SubsidiariesCompany.
Appears in 11 contracts
Samples: Support Agreement (Traws Pharma, Inc.), Agreement and Plan of Merger (Spyre Therapeutics, Inc.), Agreement and Plan of Merger (Aeglea BioTherapeutics, Inc.)
No Financial Advisors. Except as set forth on Section 2.20 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its SubsidiariesCompany.
Appears in 8 contracts
Samples: Agreement and Plan of Merger (Portage Biotech Inc.), Agreement and Plan of Merger (Anchiano Therapeutics Ltd.), Agreement and Plan of Merger and Reorganization (Sunesis Pharmaceuticals Inc)
No Financial Advisors. Except as set forth on Section 2.20 3.21 of the Company Parent Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its SubsidiariesParent.
Appears in 7 contracts
Samples: Agreement and Plan of Merger and Reorganization (Sunesis Pharmaceuticals Inc), Agreement and Plan of Merger and Reorganization (Tocagen Inc), Agreement and Plan of Merger and Reorganization (Gemphire Therapeutics Inc.)
No Financial Advisors. Except as set forth on Section 2.20 3.20 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its SubsidiariesCompany.
Appears in 7 contracts
Samples: Agreement and Plan of Merger and Reorganization (AVROBIO, Inc.), Agreement and Plan of Merger (Fresh Vine Wine, Inc.), Agreement and Plan of Merger (Neoleukin Therapeutics, Inc.)
No Financial Advisors. Except as set forth on in Section 2.20 2.21 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its Subsidiaries.
Appears in 5 contracts
Samples: Agreement and Plan of Merger and Reorganization (Bell Robert G.), Agreement and Plan of Merger and Reorganization (Tanimoto Sarina), Agreement and Plan of Merger and Reorganization (Silverback Therapeutics, Inc.)
No Financial Advisors. Except as set forth on in Section 2.20 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its Subsidiaries.
Appears in 5 contracts
Samples: Agreement and Plan of Merger and Reorganization (Kidpik Corp.), Agreement and Plan of Merger and Reorganization (Angion Biomedica Corp.), Agreement and Plan of Merger and Reorganization (AgeX Therapeutics, Inc.)
No Financial Advisors. Except as set forth on Section 2.20 2.21 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its Subsidiaries.
Appears in 3 contracts
Samples: Agreement and Plan of Merger and Reorganization (Synlogic, Inc.), Agreement and Plan of Merger and Reorganization (Mirna Therapeutics, Inc.), Agreement and Plan of Merger and Reorganization (Nivalis Therapeutics, Inc.)
No Financial Advisors. Except as set forth on in Section 2.20 3.20 of the Company Parent Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company Parent or any of its Subsidiaries.
Appears in 3 contracts
Samples: Agreement and Plan of Merger and Reorganization (Kidpik Corp.), Agreement and Plan of Merger and Reorganization (MorphImmune Inc.), Agreement and Plan of Merger and Reorganization (Immunome Inc.)
No Financial Advisors. Except as set forth on Section 2.20 4.21 of the Company Homology Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its SubsidiariesHomology.
Appears in 2 contracts
Samples: Agreement and Plan of Merger (Homology Medicines, Inc.), Agreement and Plan of Merger (Homology Medicines, Inc.)
No Financial Advisors. Except as set forth on Section 2.20 2.20 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its SubsidiariesCompany.
Appears in 2 contracts
Samples: Agreement and Plan of Merger (SciSparc Ltd.), Agreement and Plan of Merger (Anchiano Therapeutics Ltd.)
No Financial Advisors. Except as set forth on Section 2.20 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its SubsidiariesGroup.
Appears in 2 contracts
Samples: Agreement and Plan of Merger and Reorganization (Kubient, Inc.), Agreement and Plan of Merger and Reorganization (Kubient, Inc.)
No Financial Advisors. Except as set forth on Section 2.20 3.20 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its Subsidiaries.
Appears in 2 contracts
Samples: Support Agreement (Vascular Biogenics Ltd.), Agreement and Plan of Merger and Reorganization (Gemini Therapeutics, Inc. /DE)
No Financial Advisors. Except as set forth on Section 2.20 3.21 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its Subsidiaries.
Appears in 2 contracts
Samples: Support Agreement (Talaris Therapeutics, Inc.), Agreement and Plan of Merger (Zafgen, Inc.)
No Financial Advisors. Except as set forth on Section 2.20 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its Subsidiaries.with
Appears in 1 contract
Samples: Agreement and Plan of Merger (Caladrius Biosciences, Inc.)
No Financial Advisors. Except as set forth on Section 2.20 4.22 of the Company ADES Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company ADES or any of its Subsidiaries.
Appears in 1 contract
Samples: Transaction Agreement (Advanced Emissions Solutions, Inc.)
No Financial Advisors. Except as set forth on Section 2.20 3.20 of the Company Disclosure ScheduleLetter, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its SubsidiariesCompany.
Appears in 1 contract
Samples: Agreement and Plan of Merger and Reorganization (ARCA Biopharma, Inc.)
No Financial Advisors. Except as set forth on Section 2.20 2.21 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its SubsidiariesCompany.
Appears in 1 contract
Samples: Agreement and Plan of Merger (Mer Telemanagement Solutions LTD)
No Financial Advisors. Except as set forth on in Section 2.20 2.21 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its SubsidiariesSubsidiary.
Appears in 1 contract
No Financial Advisors. Except as set forth on Section 2.20 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its Subsidiaries.Company. 2.21
Appears in 1 contract
No Financial Advisors. Except as set forth on Section 2.20 3.20 of the Company Disclosure Schedule, no broker, finder finder, or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its SubsidiariesCompany.
Appears in 1 contract
Samples: Agreement and Plan of Merger (Ikena Oncology, Inc.)
No Financial Advisors. Except as set forth on in Section 2.20 of the Company Disclosure Schedule, no broker, finder finder, or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its Subsidiaries.
Appears in 1 contract
No Financial Advisors. Except as set forth on Section 2.20 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee, service fee or other fee fee, commission or commission expense in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its SubsidiariesCompany.
Appears in 1 contract
Samples: Agreement and Plan of Merger and Reorganization (OncoMed Pharmaceuticals Inc)
No Financial Advisors. Except as set forth on in Section 2.20 2.21 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its Subsidiariesthe Company Subsidiary.
Appears in 1 contract
Samples: Agreement and Plan of Merger and Reorganization (Aduro Biotech, Inc.)
No Financial Advisors. Except as set forth on Section 2.20 3.21 of the Company ADES Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company ADES or any of its Subsidiaries.
Appears in 1 contract
Samples: Securities Purchase Agreement (Advanced Emissions Solutions, Inc.)
No Financial Advisors. Except as set forth on Section 2.20 of the Company Disclosure ScheduleSchedule and other than Xxxx Xxxxxxxxxxxx Advisors LLC, no broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its Subsidiaries.
Appears in 1 contract
Samples: Agreement and Plan of Merger (Seachange International Inc)
